| Rank | Ticker | Country | Price | Revenue | Analyst Rating | Analysts | IPO Year |
|---|---|---|---|---|---|---|---|
#1 | PAYP | Japan | $20.23 | $0.00 | Buy | 9 | 2026 |
#2 | AA | United States | $65.39 | $12,831,000,000.00 | Buy | 10 | 2016 |
#3 | SON | United States | $48.84 | $7,518,753,000.00 | Buy | 9 | 2014 |
#4 | KNSA | United Kingdom | $43.05 | $677,564,000.00 | Strong Buy | 7 | 2018 |
#5 | EYE | United States | $24.15 | $1,987,488,000.00 | Strong Buy | 9 | 2017 |
#6 | VTR | United States | $82.83 | $5,833,980,000.00 | Buy | 13 | 2005 |
#7 | CALX | United States | $42.75 | $510,367,000.00 | Strong Buy | 5 | 2009 |
#8 | APEI | United States | $55.59 | $198,174,000.00 | Strong Buy | 7 | 2007 |
#9 | WLDN | United States | $76.51 | $273,352,000.00 | Strong Buy | 4 | 2006 |
#10 | WBD | United States | $26.93 | $0.00 | Buy | 21 | 2008 |
#11 | CTRE | United States | $38.09 | $476,393,000.00 | Buy | 10 | 2013 |
#12 | MEG | United States | $20.74 | $830,538,000.00 | Buy | 4 | 2020 |
#13 | ANAB | United States | $51.50 | $234,603,000.00 | Buy | 11 | 2015 |
#14 | ARQT | United States | $22.78 | $376,072,000.00 | Strong Buy | 6 | 2020 |
#15 | MIRM | United States | $91.88 | $19,138,000.00 | Strong Buy | 12 | 2019 |
#16 | IDYA | United States | $30.51 | $218,710,000.00 | Strong Buy | 16 | 2019 |
#17 | ARVN | United States | $10.35 | $262,600,000.00 | Buy | 19 | 2018 |
#18 | WK | United States | $52.10 | $884,568,000.00 | Strong Buy | 10 | 2014 |
#19 | TARS | United States | $61.25 | $451,360,000.00 | Buy | 6 | 2020 |
#20 | MAMA | United States | $13.97 | $95,420,129.00 | Strong Buy | 5 | 2011 |
#21 | TCBX | United States | $38.86 | $0.00 | Buy | 4 | 2021 |
#22 | IMAX | Canada | $36.53 | $410,212,000.00 | Strong Buy | 10 | 1997 |
#23 | MDT | Ireland | $83.70 | $33,537,000,000.00 | Buy | 21 | 2014 |
#24 | IMCR | United Kingdom | $29.34 | $249,428,000.00 | Buy | 10 | 2016 |
#25 | COCO | United States | $47.34 | $0.00 | Buy | 9 | 2021 |
#26 | RRR | United States | $55.54 | $2,011,483,000.00 | Strong Buy | 13 | 2015 |
#27 | OLLI | United States | $87.85 | $2,649,198,000.00 | Strong Buy | 13 | 2015 |
#28 | LVS | United States | $51.77 | $13,017,000,000.00 | Buy | 14 | 2004 |
#29 | KTOS | United States | $65.15 | $751,900,000.00 | Strong Buy | 18 | 1999 |
#30 | TCMD | United States | $24.34 | $0.00 | Strong Buy | 4 | 2016 |
#31 | KBR | United States | $35.05 | $5,767,000,000.00 | Buy | 8 | 2006 |
#32 | OLMA | United States | $15.27 | $0.00 | Strong Buy | 10 | 2020 |
#33 | SNDX | United States | $21.08 | $172,352,000.00 | Strong Buy | 13 | 2014 |
#34 | DBVT | France | $19.28 | $5,636,000.00 | Buy | 7 | 2014 |
#35 | GGG | United States | $82.04 | $2,236,604,000.00 | Buy | 4 | 1994 |
#36 | UAL | United States | $90.20 | $37,736,000,000.00 | Strong Buy | 17 | 1995 |
#37 | GEHC | United States | $69.80 | $20,625,000,000.00 | Buy | 13 | 2022 |
#38 | PSN | United States | $51.64 | $6,364,245,000.00 | Strong Buy | 13 | 2019 |
#39 | FE | United States | $49.47 | $15,090,000,000.00 | Buy | 16 | 2005 |
#40 | ELS | United States | $63.37 | $1,531,382,000.00 | Buy | 10 | 1994 |
#41 | CTSH | United States | $54.92 | $21,108,000,000.00 | Buy | 18 | 1998 |
#42 | TSCO | United States | $38.27 | $15,524,046,000.00 | Buy | 22 | 1996 |
#43 | CTNM | United States | $12.37 | $0.00 | Buy | 4 | 2024 |
#44 | CNR | United States | $87.20 | $0.00 | Strong Buy | 6 | N/A |
#45 | IP | United States | $33.47 | $0.00 | Buy | 10 | N/A |
#46 | SI | United States | $13.03 | $0.00 | Strong Buy | 5 | N/A |
#47 | KGC | Canada | $31.91 | $0.00 | Buy | 7 | 1994 |
#48 | NICE | Israel | $98.37 | $0.00 | Buy | 13 | N/A |
#49 | FCX | United States | $61.42 | $25,915,000,000.00 | Strong Buy | 17 | 1994 |
#50 | QGEN | Netherlands | $37.80 | $0.00 | Buy | 8 | 1998 |
The FinQuota filters have identified what they believe to be the "Best Stocks Under $100 to Buy (April 24, 2026) | FinQuota" to buy now. However, please note that this information should not be considered as financial advice, as investing involves risks. We strongly recommend consulting with a qualified financial advisor before making any decisions regarding buying or selling stocks.